Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
Akshat Jain/LinkedIn
Jul 13, 2026, 15:23

Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026

Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared a post on LinkedIn:

”’International Society on Thrombosis and Haemostasis (ISTH) 2026 meeting in Paris provided a great platform to interact with colleagues around the world and present our real world case scenario in Bleeding Disorder’s and other research work

Takeaways:

  1. Gene therapy is alive and well and powerful advances in the field coming in the next 5 years – Wolfgang Miesbach
  2. Novel drug delivery is going to change how we offer therapies . Inno8 was very exciting – Novo Nordisk
  3. Von Willebrand Disease : underserved population such as young children and women with bleeding have amazing new options that are looking beyond ‘Just Bleeding’. Sarcopenia, anemia and fatigue with therapies new target to study Octapharma
  4. Safety of Rebalancing agents assessed and more real world data very promising – Pfizer
  5. I.T.P. : subcutaneous therapy once a week targeting pro coagulation like protein C and S would add another layer of protection in addition to Rizlabrutinib from Sanofi

Women with blood disorders is finding more representation in novel therapeutics and personalized therapies Angela Weyand, Flora Peyvandi.”

Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026

Stay updated with Hemostasis Today.

Akshat Jain Angela Weyand Flora Peyvandi Gene therapy Health Hematology Hemostasis Hemostasis News Hemostasis Today ISTH 2026 Medicine thrombosis Wolfgang Miesbach
NewsFeed